These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2032474)

  • 1. Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies.
    Meulemans A; Giroux B; Hannoun P; Robine D; Henzel D
    Chemotherapy; 1991; 37(2):86-92. PubMed ID: 2032474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of two nitrosoureas, carmustine and fotemustine in rat cortex.
    Meulemans A; Giroux B; Hannoun P; Henzel D; Bizzari JP; Mohler J
    Chemotherapy; 1989; 35(5):313-9. PubMed ID: 2791708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.
    Guaitani A; Corada M; Lucas C; Lemoine A; Garattini S; Bartosek I
    Cancer Chemother Pharmacol; 1991; 28(4):293-7. PubMed ID: 1879046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of fotemustine in rat plasma by electrochemical detection.
    Bartosek I; Corada M; Dallarda S; Lucas C; Deloffre P; Guaitani A
    Xenobiotica; 1991 Feb; 21(2):235-42. PubMed ID: 2058178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain metastases of malignant melanomas].
    Boaziz C; Breau JL; Morere JF; Israël L
    Bull Cancer; 1991; 78(4):347-53. PubMed ID: 1859902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosoureas lomustine, carmustine and fotemustine induced hepatotoxic perturbations in rats: biochemical, morphological and flow cytometry studies.
    Laquerriere A; Raguenez-Viotte G; Paraire M; Bizzari JP; Paresy M; Fillastre JP; Hemet J
    Eur J Cancer; 1991; 27(5):630-8. PubMed ID: 1828975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man].
    Lucas C; Ings B; Gray AJ; Deloffre P; Lokiec F; Campbell B; Beerblock K
    Bull Cancer; 1989; 76(8):863-5. PubMed ID: 2515897
    [No Abstract]   [Full Text] [Related]  

  • 8. Focus on Fotemustine.
    De Rossi A; Rossi L; Laudisi A; Sini V; Toppo L; Marchesi F; Tortorelli G; Leti M; Turriziani M; Aquino A; Bonmassar E; De Vecchis L; Torino F
    J Exp Clin Cancer Res; 2006 Dec; 25(4):461-8. PubMed ID: 17310834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and glutathione conjugation-related degradation of fotemustine: formation and characterization of a glutathione conjugate of diethyl (1-isocyanatoethyl)phosphonate, a reactive metabolite of fotemustine.
    Brakenhoff JP; Commandeur JN; de Kanter FJ; van Baar BL; Luijten WC; Vermeulen NP
    Chem Res Toxicol; 1994; 7(3):380-9. PubMed ID: 8075370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.
    Iliadis A; Launay-Iliadis MC; Lucas C; Fety R; Lokiec F; Tranchand B; Milano G
    Eur J Cancer; 1996 Mar; 32A(3):455-60. PubMed ID: 8814692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas.
    Tranchand B; Lucas C; Biron P; Giroux B; Gordon B; Richards R; Solere P; Roux N; Evene E; Mornex F
    Cancer Chemother Pharmacol; 1993; 32(1):46-52. PubMed ID: 8462123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
    Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
    Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A probable mechanism for hyperpigmentation by fotemustine.
    Schallreuter KU; Ring J
    Dermatology; 1992; 185(1):76-7. PubMed ID: 1638080
    [No Abstract]   [Full Text] [Related]  

  • 15. A new method for the measurement of nitrosoureas in plasma: an h.p.l.c. procedure for the measurement of fotemustine kinetics.
    Gordon BH; Richards RP; Hiley MP; Gray AJ; Ings RM; Campbell DB
    Xenobiotica; 1989 Mar; 19(3):329-39. PubMed ID: 2665327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the clinical pharmacokinetics of fotemustine in various tumor indications].
    Lokiec F; Beerblock K; Deloffre P; Lucas C; Bizzari JP
    Bull Cancer; 1989; 76(10):1063-9. PubMed ID: 2635634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fotemustine for the treatment of melanoma.
    Quéreux G; Dréno B
    Expert Opin Pharmacother; 2011 Dec; 12(18):2891-904. PubMed ID: 22077794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients.
    Ings RM; Gray AJ; Taylor AR; Gordon BH; Breen M; Hiley M; Brownsill R; Marchant N; Richards R; Wallace D
    Eur J Cancer; 1990; 26(7):838-42. PubMed ID: 2145908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice.
    Ings RM; Breen M; Devereux K; Gray AJ; Edwards FE; Lucas C; Briggs M; Robinson BV; Campbell DB
    Cancer Chemother Pharmacol; 1990; 27(2):106-10. PubMed ID: 2249325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer.
    Rougier P; Chabot GG; Bonneterre J; Tigaud JM; Lucas C; Baud M; Bérille J; Gouyette A
    Eur J Cancer; 1993; 29A(2):288-9. PubMed ID: 8422301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.